# Cervical Cancer Radiotherapy by Use of VMAT, Individualized Polyradiosensitization and Interstitial Brachytherapy

> **NCT02957266** · PHASE3 · UNKNOWN · sponsor: **The National Center of Oncology, Azerbaijan** · enrollment: 400 (estimated)

## Conditions studied

- Cervical Cancer

## Interventions

- **RADIATION:** Volumetric Arc Radiotherapy
- **RADIATION:** Interstitial brachytherapy
- **DRUG:** Cisplatin
- **DRUG:** Gemcitabine
- **GENETIC:** PIK3CA
- **GENETIC:** KRAS
- **GENETIC:** BRAF
- **GENETIC:** RRM1

## Key facts

- **NCT ID:** NCT02957266
- **Lead sponsor:** The National Center of Oncology, Azerbaijan
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-03
- **Primary completion:** 2018-12
- **Final completion:** 2020-12
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2016-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02957266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02957266, "Cervical Cancer Radiotherapy by Use of VMAT, Individualized Polyradiosensitization and Interstitial Brachytherapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02957266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*